@kellieowens.bsky.social Alison Bateman-House, and I on whether AI technologies "will expand opportunities for historically overlooked patients or further concentrate attention on those already represented within existing data systems." www.tandfonline.com/doi/full/10....
Ethical and Epistemic Considerations for the Use of Artificial Intelligence in Ultra-Rare Disease Clinical Trials
Published in The American Journal of Bioethics (Vol. 26, No. 8, 2026)
tandfonline.com